UvA professors Cees Snoek and Marcel Worring are starting a new public-private research lab together with researchers from the Inception Institute of Artificial Intelligence Ltd. from the United Arab Emirates led by Professor Ling Shao. Within the new AIM lab, the researchers will focus on using artificial intelligence for medical image analysis. The lab will form part of ICAI, the national Innovation Center for Artificial Intelligence, located at Amsterdam Science Park.
Medical practice requires more and more interpretation of digital images. Human experts are expensive, error prone and get tired. Recent developments in image recognition, in particular through ‘deep learning’, have shown that computers can extract more information from images and are sometimes more reliable than people due to their increased accuracy. However, image recognition has mainly focused on everyday images such as those that can be found on Instagram and YouTube. ‘Adapting and further developing image recognition to the characteristics of medical images is an important challenge for the AIM Lab’, says Cees Snoek, one of the scientific directors of the AIM Lab. ‘From a technical perspective, work will be done on fundamental and relatively general AI models and algorithms that can be applied to specific diseases.’
Over the next five years, seven PhD researchers will work in the lab on projects that will focus, among other things, on achieving a quicker diagnosis of Alzheimer’s disease, modelling cardiac rhythms and on generating automatic reports based on X-ray images.
The AIM Lab is the seventh lab to form part of ICAI. Over the past year, AIRlab Amsterdam (a joint industry lab with Ahold Delaize), the National Police Lab (collaboration between UvA, Utrecht University and the National Police) and Elsevier AI Lab (partnership between UvA, VU University Amsterdam and Elsevier) were created.
The Inception Institute of Artificial Intelligence Ltd. (IIAI) drives excellence and leadership of AI research in the UAE and the wider world with the aim of promoting economic growth, fostering innovation and improving healthcare and people’s lives. IIAI collaborates with leading hospitals in the UAE on applying cutting-edge machine learning and computer vision techniques to revolutionize the healthcare industry through medical image computation and analysis. IIAI attracts exceptionally talented and highly motivated researchers and engineers from around the world in the areas of computer vision, machine learning and medical imaging to work across disciplines on both fundamental and applied research.
The Innovation Center for Artificial Intelligence (ICAI) is a national initiative focused on joint technology development between academia, industry and government in the area of artificial intelligence. The Netherlands has the talent, the world-class research and the longstanding tradition in AI education to be one of the world’s top ranked countries in terms of innovation power. ICAI brings these positive forces together in a unique national initiative. ICAI’s innovation strategy is organized around industry labs, these are multi-year strategic collaborations.
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News